{"id":"https://openalex.org/W1981069784","doi":"https://doi.org/10.1186/1472-6750-7-93","title":"Improved functional expression of recombinant human ether-a-go-go (hERG) K+ channels by cultivation at reduced temperature","display_name":"Improved functional expression of recombinant human ether-a-go-go (hERG) K+ channels by cultivation at reduced temperature","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W1981069784","doi":"https://doi.org/10.1186/1472-6750-7-93","mag":"1981069784","pmid":"https://pubmed.ncbi.nlm.nih.gov/18096051","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2241608"},"language":"en","primary_location":{"id":"doi:10.1186/1472-6750-7-93","doi":"https://doi.org/10.1186/1472-6750-7-93","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1472-6750-7-93","pdf_url":"https://bmcbiotechnol.biomedcentral.com/counter/pdf/10.1186/1472-6750-7-93","source":{"id":"https://openalex.org/S53489610","display_name":"BMC Biotechnology","issn_l":"1472-6750","issn":["1472-6750"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Biotechnology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmcbiotechnol.biomedcentral.com/counter/pdf/10.1186/1472-6750-7-93","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100715328","display_name":"Mao Chen","orcid":"https://orcid.org/0000-0002-4046-1165","observed_orcids":["https://orcid.org/0000-0002-4046-1165"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Mao Chen","raw_affiliation_strings":["BR&AD, GlaxoSmithKline R&D, Stevenage, UK. mark.x.chen@gsk.com","BR&AD, GlaxoSmithKline R&D, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BR&AD, GlaxoSmithKline R&D, Stevenage, UK. mark.x.chen@gsk.com","institution_ids":[]},{"raw_affiliation_string":"BR&AD, GlaxoSmithKline R&D, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012598298","display_name":"Shaun L. Sandow","orcid":"https://orcid.org/0000-0002-0753-2742","observed_orcids":["https://orcid.org/0000-0002-0753-2742"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Shaun L Sandow","raw_affiliation_strings":["Department of Physiology and Pharmacology, University of New South Wales, Sydney, Australia","Department of Physiology & Pharmacology, University of New South Wales, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiology and Pharmacology, University of New South Wales, Sydney, Australia","institution_ids":["https://openalex.org/I31746571"]},{"raw_affiliation_string":"Department of Physiology & Pharmacology, University of New South Wales, Sydney, Australia","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064320310","display_name":"Virginie Doceul","orcid":"https://orcid.org/0000-0002-6286-3405","observed_orcids":["https://orcid.org/0000-0002-6286-3405"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Virginie Doceul","raw_affiliation_strings":["BR&AD, GlaxoSmithKline R&D, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BR&AD, GlaxoSmithKline R&D, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100402034","display_name":"Yu Chen","orcid":"https://orcid.org/0000-0002-3647-2056","observed_orcids":["https://orcid.org/0000-0002-3647-2056"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Yu Chen","raw_affiliation_strings":["BR&AD, GlaxoSmithKline R&D, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BR&AD, GlaxoSmithKline R&D, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110416940","display_name":"Harper Heather","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Heather Harper","raw_affiliation_strings":["BR&AD, GlaxoSmithKline R&D, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BR&AD, GlaxoSmithKline R&D, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090954043","display_name":"Hamilton Bruce","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Bruce Hamilton","raw_affiliation_strings":["BR&AD, GlaxoSmithKline R&D, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BR&AD, GlaxoSmithKline R&D, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108519471","display_name":"Helen J. Meadows","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Helen J Meadows","raw_affiliation_strings":["BR&AD, GlaxoSmithKline R&D, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BR&AD, GlaxoSmithKline R&D, Harlow, UK","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112301925","display_name":"Derek J. Trezise","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Derek J Trezise","raw_affiliation_strings":["BR&AD, GlaxoSmithKline R&D, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BR&AD, GlaxoSmithKline R&D, Harlow, UK","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110082846","display_name":"Jeff J. Clare","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jeff J Clare","raw_affiliation_strings":["BR&AD, GlaxoSmithKline R&D, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BR&AD, GlaxoSmithKline R&D, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5100715328"],"corresponding_institution_ids":["https://openalex.org/I188950975"],"apc_list":{"value":2990,"currency":"USD","value_usd":2990},"apc_paid":{"value":2990,"currency":"USD","value_usd":2990},"fwci":0.6618,"has_fulltext":true,"cited_by_count":32,"citation_normalized_percentile":{"value":0.64917198,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"7","issue":"1","first_page":"93","last_page":"93"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.9071999788284302,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.9071999788284302,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.06069999933242798,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11663","display_name":"Viral Infectious Diseases and Gene Expression in Insects","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/herg-channel","display_name":"hERG","score":0.9750000238418579},{"id":"https://openalex.org/keywords/protein-trafficking","display_name":"protein trafficking","score":0.46299999952316284},{"id":"https://openalex.org/keywords/membrane-protein-expression","display_name":"membrane protein expression","score":0.7080000042915344},{"id":"https://openalex.org/keywords/drug-induced-long-qt-syndrome","display_name":"drug-induced long QT syndrome","score":0.7870000004768372},{"id":"https://openalex.org/keywords/cho-k1-cells","display_name":"CHO-K1 cells","score":0.7599999904632568},{"id":"https://openalex.org/keywords/cytoplasmic-vesicles","display_name":"cytoplasmic vesicles","score":0.7760000228881836},{"id":"https://openalex.org/keywords/thapsigargin","display_name":"thapsigargin","score":0.8870000243186951},{"id":"https://openalex.org/keywords/nocodazole","display_name":"nocodazole","score":0.996999979019165},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.4480000138282776}],"concepts":[{"id":"https://openalex.org/C2779362680","wikidata":"https://www.wikidata.org/wiki/Q905000","display_name":"hERG","level":3,"score":0.9360132217407227},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.903512179851532},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.6549125909805298},{"id":"https://openalex.org/C90559484","wikidata":"https://www.wikidata.org/wiki/Q778379","display_name":"Expression (computer science)","level":2,"score":0.5093120336532593},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4373972713947296},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3397555351257324},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2688765525817871},{"id":"https://openalex.org/C83743174","wikidata":"https://www.wikidata.org/wiki/Q423778","display_name":"Potassium channel","level":2,"score":0.2500903904438019},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.21177813410758972},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1223478615283966},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.07096496224403381},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001693","descriptor_name":"Biological Transport, Active","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010627","descriptor_name":"Phenethylamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013696","descriptor_name":"Temperature","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015739","descriptor_name":"Nocodazole","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017301","descriptor_name":"Ca(2+) Mg(2+)-ATPase","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018929","descriptor_name":"Cell Culture Techniques","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019284","descriptor_name":"Thapsigargin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D021381","descriptor_name":"Protein Transport","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D022161","descriptor_name":"Transport Vesicles","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D026902","descriptor_name":"Potassium Channel Blockers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051638","descriptor_name":"Ether-A-Go-Go Potassium Channels","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D051638","descriptor_name":"Ether-A-Go-Go Potassium Channels","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1186/1472-6750-7-93","doi":"https://doi.org/10.1186/1472-6750-7-93","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1472-6750-7-93","pdf_url":"https://bmcbiotechnol.biomedcentral.com/counter/pdf/10.1186/1472-6750-7-93","source":{"id":"https://openalex.org/S53489610","display_name":"BMC Biotechnology","issn_l":"1472-6750","issn":["1472-6750"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Biotechnology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:776217","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2241608","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:2241608","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2241608","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Biotechnol","raw_type":"Text"},{"id":"pmid:18096051","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18096051","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC biotechnology","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-02655540v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.inrae.fr/hal-02655540","pdf_url":"https://hal.inrae.fr/hal-02655540v1/file/1472-6750-7-93_1.pdf","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Biotechnology, 2007, 7, pp.e-93. ⟨10.1186/1472-6750-7-93⟩","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:21bceb19c681429fb515a06af648c80a","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/21bceb19c681429fb515a06af648c80a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Biotechnology, Vol 7, Iss 1, p 93 (2007)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/1472-6750-7-93","doi":"https://doi.org/10.1186/1472-6750-7-93","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1472-6750-7-93","pdf_url":"https://bmcbiotechnol.biomedcentral.com/counter/pdf/10.1186/1472-6750-7-93","source":{"id":"https://openalex.org/S53489610","display_name":"BMC Biotechnology","issn_l":"1472-6750","issn":["1472-6750"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Biotechnology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1392986007","display_name":"Understanding the relationship between arterial structure and divergent vasodilatory function in health and disease","funder_award_id":"401112","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320311738","display_name":"Oxford Brookes University","ror":"https://ror.org/04v2twj65"},{"id":"https://openalex.org/F4320319992","display_name":"British Heart Foundation","ror":"https://ror.org/02wdwnk04"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"},{"id":"https://openalex.org/F4320334705","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1981069784.pdf","grobid_xml":"https://content.openalex.org/works/W1981069784.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W1490688374","https://openalex.org/W1501389915","https://openalex.org/W1507386113","https://openalex.org/W1604262633","https://openalex.org/W1981088394","https://openalex.org/W1985912434","https://openalex.org/W1993767732","https://openalex.org/W2002244218","https://openalex.org/W2014767218","https://openalex.org/W2023317996","https://openalex.org/W2031079874","https://openalex.org/W2040826404","https://openalex.org/W2048593770","https://openalex.org/W2058386795","https://openalex.org/W2059217828","https://openalex.org/W2078646599","https://openalex.org/W2092956321","https://openalex.org/W2096863594","https://openalex.org/W2097651191","https://openalex.org/W2115617146","https://openalex.org/W2119564057","https://openalex.org/W2119748918","https://openalex.org/W2122280687","https://openalex.org/W2127611110","https://openalex.org/W2127776881","https://openalex.org/W2128571608","https://openalex.org/W2132027627","https://openalex.org/W2134867760","https://openalex.org/W2152641996","https://openalex.org/W2158905026","https://openalex.org/W2170350973","https://openalex.org/W2403995597","https://openalex.org/W4242142365"],"related_works":["https://openalex.org/W1599416285","https://openalex.org/W3094163120","https://openalex.org/W2427765116","https://openalex.org/W2791743537","https://openalex.org/W7197031884","https://openalex.org/W2085048839","https://openalex.org/W2169070640","https://openalex.org/W4414445912","https://openalex.org/W4400262595","https://openalex.org/W2395296086"],"abstract_inverted_index":{"BACKGROUND:":[0],"HERG":[1],"potassium":[2],"channel":[3,111],"blockade":[4],"is":[5,23],"the":[6,28,47,64,83,108,116,122,158,180,187,204,207,213,241,255,264,282],"major":[7],"cause":[8,16],"for":[9,39,268],"drug-induced":[10],"long":[11],"QT":[12],"syndrome,":[13],"which":[14,192],"sometimes":[15],"cardiac":[17,44],"disrhythmias":[18],"and":[19,66,94,148,197,262],"sudden":[20],"death.":[21],"There":[22],"a":[24],"strong":[25],"interest":[26],"in":[27,104,115,195,203,222],"pharmaceutical":[29],"industry":[30],"to":[31,36,62,81,219,253,270],"develop":[32],"high":[33],"quality":[34,265],"medium":[35,269],"high-throughput":[37,271],"assays":[38,267],"detecting":[40],"compounds":[41],"with":[42,107,151,186,212,240],"potential":[43],"liability":[45],"at":[46,56,126,134,144,173,199,225,231,247],"earliest":[48],"stages":[49],"of":[50,54,69,77,85,110,160,179,189,206,245,258,266,284],"drug":[51],"development.":[52],"Cultivation":[53],"cells":[55,246],"lower":[57,86,135,200],"temperature":[58,87,249],"has":[59],"been":[60],"used":[61,252],"improve":[63,263],"folding":[65],"membrane":[67,260],"localization":[68],"trafficking":[70,215,283],"defective":[71],"hERG":[72,92,100,139,165,182,223,285],"mutant":[73],"proteins.":[74],"The":[75,177],"objective":[76],"this":[78,149],"study":[79],"was":[80,101,129,171,184],"investigate":[82],"effect":[84],"maintenance":[88,244],"on":[89,121,281],"wild":[90],"type":[91,99],"expression":[93,159,257],"assay":[95],"performance.":[96],"RESULTS:":[97],"Wild":[98],"stably":[102],"expressed":[103],"CHO-K1":[105],"cells,":[106],"majority":[109,178],"protein":[112,140,183,286],"being":[113],"located":[114],"cytoplasm,":[117],"but":[118,229],"relatively":[119],"little":[120],"cell":[123,163],"surface.":[124],"Expression":[125],"both":[127],"locations":[128],"increased":[130,194],"several-fold":[131],"by":[132,167],"cultivation":[133],"growth":[136,289],"temperatures.":[137],"Intracellular":[138],"levels":[141],"were":[142],"highest":[143],"27":[145],"degrees":[146,175,227,233],"C":[147],"correlated":[150],"maximal":[152],"3H-dofetilide":[153],"binding":[154],"activity.":[155],"In":[156,274],"contrast,":[157],"functionally":[161],"active":[162],"surface-associated":[164],"measured":[166],"patch":[168],"clamp":[169],"electrophysiology":[170],"optimal":[172],"30":[174,232],"C.":[176,234],"cytoplasmic":[181,190],"associated":[185],"membranes":[188],"vesicles,":[191],"markedly":[193],"quantity":[196],"size":[198],"temperatures":[201],"or":[202],"presence":[205],"Ca2+-ATPase":[208],"inhibitor,":[209],"thapsigargin.":[210],"Incubation":[211],"endocytic":[214],"blocker,":[216],"nocodazole,":[217],"led":[218],"an":[220],"increase":[221],"activity":[224],"37":[226],"C,":[228],"not":[230],"CONCLUSION:":[235],"Our":[236],"results":[237,277],"are":[238],"consistent":[239],"concept":[242],"that":[243],"reduced":[248],"can":[250],"be":[251],"boost":[254],"functional":[256],"difficult-to-express":[259],"proteins":[261],"compound":[272],"screening.":[273],"addition,":[275],"these":[276,288],"shed":[278],"some":[279],"light":[280],"under":[287],"conditions.":[290]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}